Skip to main content

Table 1 Comparison of basic information and obesity measurement indicators in the subjects

From: Clinical significance of obesity measurement indicators and carotid artery plaques in type 2 diabetes

Variable

NCP(n = 617)

WCP(n = 392)

P

Adjust p

Female [n(%)]

233(37.8%)

134(34.2%)

0.249

0.435

Age (year)

52.00(43.00,59.00)

60.00(53.00,66.00)

 < 0.001

 < 0.001

SBP(mmHg)

75(68.00,83.00)

75.00(66.00,81.00)

0.094

0.187

DBP(mmHg)

124.00(114.00,136.00)

128.00(116.00,141.00)

0.004

0.017

Disease duration (year)

2.00(0.00,8.41)

5.00(0.08,11.00)

 < 0.001

 < 0.001

Hypertensive[n(%)]

231 (37%)

168 (43%)

0.086

0.179

Antihypertensive drugs[n(%)]

211 (34%)

125 (32%)

0.448

0.582

smoking[n(%)]

156 (25%)

102 (26%)

0.794

0.855

Oral hypoglycemic drugs [n(%)]

345 (56%)

232 (59%)

0.307

0.464

Insulin[n(%)]

282 (46%)

165 (42%)

0.260

0.435

Antihyperlipidemics[n(%)]

46 (7.5%)

37 (9.4%)

0.264

0.435

BMI(kg/m2)

23.95(22.20,26.33)

24.15(22.28,26.08)

0.662

0.756

HbA1c(%)

9.80(8.20,11.20)

9.80(8.20,11.50)

0.377

0.555

FPG(mmol/L)

10.24(8.14,13.00)

10.21(7.85,13.12)

0.956

0.982

2 hPG(mmol/L)

19.18(16.07,22.90)

19.47(15.56,22.64)

0.930

0.982

FIns(uIU/ml)

5.97(3.67,9.95)

6.84(3.76,10.82)

0.052

0.126

2 hIns (uIU/ml)

21.56(13.15,39.50)

25.07(13.44,42.02)

0.148

0.276

TG (mmol/L)

1.77(1.26,2.57)

1.75(1.21,2.62)

0.591

0.715

TC (mmol/L)

4.83(4.25,5.54)

4.90(4.12,5.74)

0.441

0.582

HDL-c (mmol/L)

1.10(0.92,1.37)

1.15(0.96,1.35)

0.124

0.240

LDL-c (mmol/L)

2.82(2.32,3.45)

2.88(2.24,3.57)

0.613

0.715

BUN (U/L)

5.14(4.38,6.19)

5.57(4.61,6.62)

 < 0.001

0.001

Scr (umol/L)

56.60(47.73,67.68)

60.30(49.70,70.90)

0.001

0.003

UA (umol/L)

275.50(222.50,325.75)

285.00(227.00,346.00)

0.031

0.086

WHR

0.93(0.89,0.96)

0.93(0.90,0.97)

0.002

0.076

WHtR

0.53(0.50,0.56)

0.54(0.51,0.58)

 < 0.001

0.004

VAI

2.57(1.59,4.29)

2.34(1.53,4.12)

0.249

0.464

CVAI

109.90(85.04,132.89)

120.24(95.92,142.19)

 < 0.001

 < 0.001

LAP

47.81(29.12,75.73)

49.50(30.42,73.71)

0.577

0.803

BRI

3.93(3.36,4.57)

4.12(3.47,4.89)

 < 0.001

0.003

BAI

25.95(23.79,28.88)

26.81(24.00,30.19)

0.010

0.039

ABSI

0.08(0.08,0.08)

0.08(0.08,0.09)

 < 0.001

0.001

AVI

7.94(7.05,8.90)

8.12(7.16,9.22)

0.024

0.076

HOMA-IR

2.77(1.69,4.30)

2.73(1.87,4.92)

0.081

0.176

  1. Note: SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood urea nitrogen, HbA1c glycosylated hemoglobin c, FPG fasting plasma glucose, 2 hPG postprandial plasma glucose, FIns fasting plasma insulin, 2 hIns postprandial plasma insulin, WHR Waist-to-Hip Ratio, WHtR Waist-to-Height Ratio, VAI Visceral Adiposity Index, CVAI Chinese Visceral Adiposity Index, LAP Lipid Accumulation Product, BRI Body Roundness Index, BAI Body Adiposity Index, ABSI A Body Shape Index, AVI Abdominal Volume Index, HOMA-IR Homeostasis Model Assessment of Insulin Resistance